Editorial: infliximab de-escalation in inflammatory bowel disease using a therapeutic drug monitoring strategy—early promise but more data needed

David J. Gibson, Mark G. Ward

Research output: Contribution to journalEditorialOtherpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)816-817
Number of pages2
JournalAlimentary Pharmacology & Therapeutics
Issue number6
Publication statusPublished - Mar 2019

Cite this